Diabetes | 2021

Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR‐TIMI 53 cardiovascular outcomes trials

 
 
 
 
 
 
 

Abstract

To provide evidence on the cardiovascular and renal safety of metformin in chronic kidney disease (CKD) stages 3 to 4.

Volume 23
Pages 1101 - 1110
DOI 10.1111/dom.14313
Language English
Journal Diabetes

Full Text